A major goal of the Hale Family Center For Pancreatic Cancer Research is to identify novel therapies for pancreatic cancer patients in the form of chemical or immunological agents, as well as novel drug combinations. We are committed to making these new lines of treatment available to patients.
We are actively seeking partnerships with industry in both the pharmaceutical sciences and in biotechnology and we welcome new alliances. Please contact us with specific inquiries about potential collaborative endeavors.